This poster describes registry data collection and the data access and governance framework.
Le Tourneau C, et al., WAYFIND-R: A Global Initiative Empowering Research in Precision Oncology.
Clinical Cancer Genomics Conference 2025, poster# PP03.
This publication describes core oncology variables along the patient journey and critical genomic testing data.
Dienstmann R., et al., Core variables for real-world clinico-genomic data collection in precision oncology.
ESMO RWD & DO 2025.
This poster describes the impact of timing of next-generation sequencing (NGS) on therapy selection in lung cancer.
Dienstmann R., et al., Timing of next-generation sequencing (NGS) relative to first line therapy in lung cancer: insights from the global WAYFIND-R registry.
ISPOR Europe 2024, Poster # RWD111.
This poster describes next-generation sequencing (NGS) practice in the most common cancer types.
Le Tourneau C., et al., Next-generation sequencing (NGS) in routine care: Medical practice in 24 countries from the pan-cancer WAYFIND-R registry.
ESMO 2024, poster# 88P.
Academic researchers can submit their own research proposals to request access to data from the WAYFIND-R registry database.
We are delighted to inform that investigators and academic researchers can request access to the global WAYFIND-R database.
This poster describes how research is empowered by a seamless data flow and research-ready data
Stone T., et al., Empowering research with seamless data flow and research-ready, anonymized data in OMOP CDM: Learnings from the design of WAYFIND-R, a global precision oncology registry and research platform.
OHDSI Europe Symposium 2024.
WAYFIND-R Meet the Investigator Onsite Meeting at ESMO 2024
At this event, investigators can get an update on the current status of WAYFIND-R and meet other investigators from around the world who are involved in this major project.
This poster reports the first descriptive analysis of the global WAYFIND-R cohort
Blay J.-Y., et al., WAYFIND-R: A global, real-world database of patients (pts) with a solid tumour profiled with next-generation sequencing (NGS).
ESMO 2023, poster # 206P.
This poster describes socio-demographic and socio-economic characteristics of the global WAYFIND-R population
Hackshaw A., et al., WAYFIND-R: A Global, Real-World Precision Oncology Registry – Socioeconomic Features.
ISPOR Europe 2023, poster #RWD111.
Launch of the WAYFIND-R Data Sharing and Collaboration Platform!
The WAYFIND-R team is excited to announce the launch of the WAYFIND-R Data Sharing and Collaboration Platform. This platform provides the medical and scientific community with access to high-quality data and enables research collaborations to help advance precision oncology.
This poster highlights the key features of the WAYFIND-R RWD Registry for Solid Tumors with NGS Testing
Le Tourneau C., et al., WAYFIND-R: Delivering a high-quality real-world data (RWD) global registry of patients diagnosed with a solid tumor and profiled with next-generation sequencing (NGS).
AACR Annual Meeting 2022, poster #4094.
This poster conceptualizes the core variables within the WAYFIND-R registry and how it supports future research with a harmonized approach
Dienstmann R., et al., Conceptualization of core clinico-molecular variables for registries enrolling patients diagnosed with a solid tumor and profiled with next-generation sequencing (NGS).
AACR Annual Meeting 2022, poster #5246.
This publication in the JCO Precision Oncology discusses the approach to solving the complex clinicogenomic data landscape in precision oncology and the learning from WAYFIND-R
Le Tourneau, C., et al., An Approach to Solving the Complex Clinicogenomic Data Landscape in Precision Oncology: Learnings From the Design of WAYFIND-R, a Global Precision Oncology Registry.
JCO Precis Oncol. 2022;6:e2200019.
If you are interested in joining WAYFIND-R, please contact us by filling out the form below to learn more about eligibility criteria and the next steps.